Author:
Florman S.,Alloway R.,Kalayoglu M.,Lake K.,Bak T.,Klein A.,Klintmalm G.,Busque S.,Brandenhagen D.,Lake J.,Wisemandle K.,Fitzsimmons W.,First M.R.
Reference6 articles.
1. New drugs to improve transplant outcomes;First;Transplantation,2004
2. Patient non-compliance: a major cause of late graft failure in cyclosporine-treated renal transplants;Didlake;Transplant Proc,1998
3. Frequency and impact of nonadherence to immunosuppressants after transplantation: a systematic review;Butler;Transplantation,2004
4. A comparison of the two-sided tests procedure and the power approach for assessing the equivalence of average bioavailability;Schuirmann;J Pharmacokin Biopharm,1987
5. Guidance for Industry. Bioavailability and bioequivalence studies for orally administered drug products—general considerations. U.S. Department of Health, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), July 2002
Cited by
87 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献